Mary Romano^2-3, Vanessa Ferraro^1-2*, Jose Luis Vallejo-Garcia^1,2, Alessandro Randazzo¹ and Paolo Vinciguerra^1,2

¹IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
²Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy
³Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania Luigi Vanvitelli, Neaples, Italy

*Corresponding Author: Vanessa Ferraro, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.

Received: July 21, 2022; Published: July 29, 2022

Abstract

Purpose: To give clinical feedback to what the literature states about the different treatment of Central Serous Corioretinopathy (CSCR), outlining how, through different treatments customized on different characteristics of the patient it is possible to obtain excellent results of visual recovery.

Observations: While in acute forms a broad consensus has been reached on whether a wait-and-see attitude can be taken, in chronic forms the visual prognosis is very much influenced by the treatment to which it is subjected.

Conclusions: In the acute form (aCSCR), which has a relatively high rate of spontaneous resolution, an effective treatment should ideally prevent recurrences and subsequent disease progression. In the chronic form (cCSCR), the primary aim of treatment is currently to achieve and maintain the complete resolution of subretinal fluid.

Keywords: Subthreshold Micropulse Laser; Argon Laser; Eplerenone; Photodinamyc

References

1. Sivaprasad S., et al. “Micropulsed diode laser therapy: evolution and clinical applications”. Survey of Ophthalmology 6 (2010): 516-530.
2. Chen SN., et al. “Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage”. Ophthalmology 12 (2008): 2229-2234.
3. Ricci F., et al. “Indocyanine green dye-enhanced micropulsed diode laser: a novel approach to subthreshold RPE treatment in a case of central serous chorioretinopathy”. European Journal of Ophthalmology 1 (2004): 74-82.
4. Roisman L., et al. “Micropulse diode laser treatment for chronic central serous chorioretinopathy: a randomized pilot trial”. Ophthalmic Surgery, Lasers and Imaging Retina 5 (2013): 465-470.
5. Romano MR., et al. “An international collaborative evaluation of central serous chorioretinopathy: different therapeutic approaches and review of literature. The European Vitreoretinal Society central serous chorioretinopathy study”. Acta Ophthalmology (2019).
6. Chen SN., et al. “Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage”. Ophthalmology12 (2005): 2229-2234.
7. Chan WM., et al. “Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level”. British Journal of Ophthalmology 12 (2003): 1453-1458.
8. van Rijssen TJ., et al. “Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakage”. Graefe's Archive for Clinical and Experimental Ophthalmology 7 (2019): 1419-1425.
9. Daruich A., et al. “Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis”. Progress in Retinal and Eye Research 48 (2015): 82-118.
10. Gemenetzi M., et al. “Central serous chorioretinopathy: an update on pathogenesis and treatment”. Eye (Lond)12 (2010): 1743-1756.
11. van Rijssen TJ., et al. “Central serous chorioretinopathy: Towards an evidence-based treatment guideline”. Progress in Retinal and Eye Research 73 (2019): 100770.

Citation

Citation: Mary Romano., et al. “Different Therapeutic Approaches in Central Serous Corioretinopathy: A Case Series".Acta Scientific Ophthalmology 5.8 (2022): 101-105.

Copyright

Copyright: © 2022 Vanessa Ferraro., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.